hotspot -WSS

hotspot

author：entertainment 2025-09-06 01:29:25 - browse：328

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Beam Therapeutics to lay off 20% of its staff, re

Wikipedia

WSS

North Korean leader's powerful sister says warplanes repelled US spy plane

Another man arrested in connection with shooting at Kansas nightclub

How redistricting in 6 states could affect who controls Congress

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

FDA gives detailed accounting of AI

Wikipedia

hotspot

focus

Wildfire smoke exposes gaps in outdoor worker protections

Lawmakers consider Medicare pay reforms for doctors

Malaria cases in Florida and Texas: Here’s what you need to know

Solve the antibiotic resistance crisis with preventive drugs

Peter Hotez and the public health issue of online harassment

How corporate America is slashing DEI workers amid backlash to diversity programs

Duchenne breakthrough therapy leaves behind pioneering families

North Korean leader's powerful sister says warplanes repelled US spy plane

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Beam Therapeutics to lay off 20% of its staff, re

explore

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

UPS workers' union leader explains what's at stake as strike edges closer

Solve the antibiotic resistance crisis with preventive drugs

What to know about a major upcoming Wegovy heart health study

STAT Summit: Michael J. Fox on progress in Parkinson's research

How climate

hotspot

knowledge

Wikipedia

hotspot